ACTA1 and neoplasm: In contrast, studies ablating αSMA CAFs resulted in poorly differentiated tumours and shortened survival implying that αSMA‐expressing CAFs, at least in early pancreatic lesions, exhibit tumour‐suppressive activity mediated via immune activation and physical constraint [232, 233].